 There is lack of consensus guidelines for treatment of anti-TB drug induced liver damage Whether the re-introduction should take place with all the drugs given together in full doses which reduces the chance of resistance and cost to the patient or in a phased manner. There is lack of studies which compared different regimens of re-introduction of anti-TB drugs. 